| Gregory Ryan Sutton, MD | |
|
2200 E 3rd St, Suite 100, Chattanooga, TN 37404-2744 | |
| (423) 698-1844 | |
| (423) 624-2226 |
| Full Name | Gregory Ryan Sutton |
|---|---|
| Gender | Male |
| Speciality | Hematology/oncology |
| Experience | 15 Years |
| Location | 2200 E 3rd St, Chattanooga, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255575270 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 47962 (Tennessee) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| North Georgia Home Health Agency, An Amedysis Comp | Ringgold, GA | Home health agency |
| Parkridge Medical Center | Chattanooga, TN | Hospital |
| Memorial Healthcare System, Inc | Chattanooga, TN | Hospital |
| Erlanger Medical Center | Chattanooga, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Tennessee Oncology, Pllc | 4688586134 | 223 |
| Tennessee Oncology, Pllc | 4688586134 | 223 |
News Archive
Oksana Zinchenko, Research Fellow at the Institute of Cognitive Neuroscience, HSE University, has conducted meta-analysis of 17 articles to find out which areas of the brain are involved decision-making for rendering social punishment.
Almost 10 percent of the nation's entire population live with substance use disorder, but many struggle to find the right help – a task which is made more difficult because there is no standardized rating system to ensure the quality of care within specialized drug treatment facilities.
PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and infectious diseases, has successfully completed a second Phase 1B clinical safety and pilot efficacy study with PMX-60056, a small synthetic molecule designed to reverse heparin and low molecular weight heparin anticoagulants.
QLT Inc. has announced a ruling in the on-going litigation between plaintiff TAP Pharmaceutical Products, Inc. and its co-plaintiffs and defendants QLT USA, Inc. and Sanofi-Synthelabo Inc., a member of the Sanofi-aventis Group.
› Verified 9 days ago
| Entity Name | Tennessee Oncology, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811955917 PECOS PAC ID: 4688586134 Enrollment ID: O20031103000534 |
News Archive
Oksana Zinchenko, Research Fellow at the Institute of Cognitive Neuroscience, HSE University, has conducted meta-analysis of 17 articles to find out which areas of the brain are involved decision-making for rendering social punishment.
Almost 10 percent of the nation's entire population live with substance use disorder, but many struggle to find the right help – a task which is made more difficult because there is no standardized rating system to ensure the quality of care within specialized drug treatment facilities.
PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and infectious diseases, has successfully completed a second Phase 1B clinical safety and pilot efficacy study with PMX-60056, a small synthetic molecule designed to reverse heparin and low molecular weight heparin anticoagulants.
QLT Inc. has announced a ruling in the on-going litigation between plaintiff TAP Pharmaceutical Products, Inc. and its co-plaintiffs and defendants QLT USA, Inc. and Sanofi-Synthelabo Inc., a member of the Sanofi-aventis Group.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Gregory Ryan Sutton, MD Po Box 440100, Nashville, TN 37244-0100 Ph: (615) 329-0570 | Gregory Ryan Sutton, MD 2200 E 3rd St, Suite 100, Chattanooga, TN 37404-2744 Ph: (423) 698-1844 |
News Archive
Oksana Zinchenko, Research Fellow at the Institute of Cognitive Neuroscience, HSE University, has conducted meta-analysis of 17 articles to find out which areas of the brain are involved decision-making for rendering social punishment.
Almost 10 percent of the nation's entire population live with substance use disorder, but many struggle to find the right help – a task which is made more difficult because there is no standardized rating system to ensure the quality of care within specialized drug treatment facilities.
PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and infectious diseases, has successfully completed a second Phase 1B clinical safety and pilot efficacy study with PMX-60056, a small synthetic molecule designed to reverse heparin and low molecular weight heparin anticoagulants.
QLT Inc. has announced a ruling in the on-going litigation between plaintiff TAP Pharmaceutical Products, Inc. and its co-plaintiffs and defendants QLT USA, Inc. and Sanofi-Synthelabo Inc., a member of the Sanofi-aventis Group.
› Verified 9 days ago
Dr. Pamela Rani Sud, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 725 Glenwood Drive, Suite E-500, Chattanooga, TN 37404 Phone: 423-495-2635 Fax: 423-495-2638 | |
David Shved, D.O. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 975 E 3rd St, Chattanooga, TN 37403 Phone: 423-778-5179 Fax: 423-778-2108 | |
Megan J Coylewright, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 975 E 3rd St, Chattanooga, TN 37403 Phone: 423-778-8258 | |
Dr. Charles Robert Bosshardt, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2515 Desales Ave Ste 206, Chattanooga, TN 37404 Phone: 423-698-8101 Fax: 423-698-3450 | |
Dr. Elise Helene Marshall, DO Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 605 Glenwood Dr Ste 300, Chattanooga, TN 37404 Phone: 423-495-2690 Fax: 423-495-2698 | |
Dr. Joshua Warner Hornsby, M.D. Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 979 E 3rd St Ste A-440, Chattanooga, TN 37403 Phone: 423-778-2867 Fax: 423-778-2866 | |
Dr. Donald Franklin Mackler, MD Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 721 Glenwood Dr, Ste. W552, Chattanooga, TN 37404 Phone: 423-629-6258 Fax: 423-629-9531 |